We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+3.31%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$43.8B
AUM Growth
+$1B
(+2.3%)
Cap. Flow
-$59.5M
Cap. Flow
% of AUM
-0.14%
Top 10 Holdings %
Top 10 Hldgs %
14.97%
Holding
3,057
New
207
Increased
1,365
Reduced
1,344
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXC Technology
DXC
|
+$40.8M |
| 2 |
NXP Semiconductors
NXPI
|
+$30.9M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$26.7M |
| 4 |
Meta Platforms (Facebook)
META
|
+$17M |
| 5 |
Amazon
AMZN
|
+$14.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
YHOO
Yahoo Inc
YHOO
|
+$68.4M |
| 2 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$29.2M |
| 3 |
Apple
AAPL
|
+$23.6M |
| 4 |
WWAV
The WhiteWave Foods Company
WWAV
|
+$20.5M |
| 5 |
VAL
Valspar
VAL
|
+$18.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.4% |
| 2 | Technology | 15.29% |
| 3 | Healthcare | 13.69% |
| 4 | Industrials | 10.84% |
| 5 | Consumer Discretionary | 9.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VIVS
2576
VivoSim Labs
VIVS
$1.21M
| $290K | ﹤0.01% |
460
+19
| +4% | +$12.8K |
|
2577
Global Industrial
GIC
$1.38B
| $289K | ﹤0.01% |
15,372
+88
| +0.6% | +$1.38K |
|
|
GLDD
2578
DELISTED
Great Lakes Dredge & Dock
GLDD
| $287K | ﹤0.01% |
66,765
-6,605
| -9% | -$28.8K |
|
2579
Cerus
CERS
$575M
| $285K | ﹤0.01% |
113,726
-63
| -0.1% | -$202 |
|
|
BOJA
2580
DELISTED
Bojangles', Inc. Common Stock
BOJA
| $285K | ﹤0.01% |
+17,539
| New | +$323K |
|
2581
Daily Journal
DJCO
$826M
| $284K | ﹤0.01% |
1,376
-79
| -5% | -$16.6K |
|
2582
Omega Flex
OFLX
$292M
| $284K | ﹤0.01% |
4,411
-410
| -9% | -$23.7K |
|
|
BFIN
2583
DELISTED
BankFinancial
BFIN
| $283K | ﹤0.01% |
18,972
-1,530
| -7% | -$22.6K |
|
2584
Corbus Pharmaceuticals
CRBP
$165M
| $283K | ﹤0.01% |
+1,499
| New | +$294K |
|
|
CNCE
2585
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $283K | ﹤0.01% |
20,253
+1,500
| +8% | +$22.1K |
|
2586
Medpace
MEDP
$16.3B
| $282K | ﹤0.01% |
9,726
+1,140
| +13% | +$32K |
|
2587
Mitek Systems
MITK
$756M
| $282K | ﹤0.01% |
33,626
+1,927
| +6% | +$15.7K |
|
2588
NRC Health Common Stock
NRC
$412M
| $282K | ﹤0.01% |
10,467
-697
| -6% | -$17K |
|
2589
Regional Management Corp
RM
$390M
| $282K | ﹤0.01% |
11,922
-750
| -6% | -$15.8K |
|
|
CTO
2590
CTO Realty Growth
CTO
$756M
| $281K | ﹤0.01% |
18,192
-1,455
| -7% | -$21.6K |
|
2591
Utah Medical Products
UTMD
$226M
| $281K | ﹤0.01% |
3,881
-425
| -10% | -$28K |
|
|
MR
2592
DELISTED
Montage Resources Corporation Common Stock
MR
| $280K | ﹤0.01% |
6,537
+2,464
| +60% | +$86.2K |
|
2593
Lands' End
LE
$378M
| $279K | ﹤0.01% |
18,737
-1,585
| -8% | -$30.2K |
|
|
TNAV
2594
DELISTED
Telenav Inc.
TNAV
| $279K | ﹤0.01% |
34,471
-2,740
| -7% | -$23.3K |
|
2595
Home Bancorp
HBCP
$558M
| $277K | ﹤0.01% |
+6,516
| New | +$238K |
|
|
BFYT
2596
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $277K | ﹤0.01% |
+11,795
| New | +$235K |
|
2597
NCS Multistage Holdings
NCSM
$116M
| $276K | ﹤0.01% |
+549
| New | +$258K |
|
|
MCBC
2598
DELISTED
Macatawa Bank Corp
MCBC
| $276K | ﹤0.01% |
28,967
+750
| +3% | +$7.19K |
|
|
ADXS
2599
DELISTED
Advaxis Inc
ADXS
| $276K | ﹤0.01% |
2,834
+102
| +4% | +$11.9K |
|
2600
Intellia Therapeutics
NTLA
$1.51B
| $275K | ﹤0.01% |
+17,166
| New | +$240K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2017 Portfolio in Review
As of Q2 2017, RhumbLine Advisers held 3,057 positions worth $43.8B, up 2.3% from $42.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers's Q2 2017 filing shows 207 new, 1,365 increased, 1,344 reduced and 128 closed positions. Its largest new stake was DXC Technology: 615,360 shares worth $40.8M. The largest sale was Yahoo Inc, an estimated $68.4M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
- RhumbLine Advisers's largest Q2 2017 buy was DXC Technology: 615,360 shares worth $40.8M.
- RhumbLine Advisers added most to IHS Markit Ltd. Common Shares in Q2 2017, an estimated $26.7M increase.
- RhumbLine Advisers's biggest Q2 2017 reduction was Apple, cutting an estimated $23.6M.
- RhumbLine Advisers fully exited Yahoo Inc in Q2 2017, selling an estimated $68.4M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $43.8B portfolio in Q2 2017.
- RhumbLine Advisers opened 207 new positions and closed 128 in Q2 2017.
- RhumbLine Advisers's portfolio value rose 2.3% quarter-over-quarter to $43.8B.
Based on RhumbLine Advisers's 13F filing for Q2 2017, filed 2 Aug 2017.